Close this search box.

McDonnell now CEO of Agilent

ARTICLE | Management Tracks

Plus: Dubensky to lead ImmuneSensor and updates from NORD and Epsilogen

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst  

May 2, 2024 12:34 AM UTC

Padraig McDonnell is now CEO of Agilent Technologies Inc. (NYSE:A), having been named CEO-elect in February when he was COO. McDonnell joined Agilent in 1997 and succeeds Mike McMullen, who will serve as an adviser until he retires on Oct. 31. 

ImmuneSensor Therapeutics Inc. named Thomas Dubensky president and CEO. Dubensky was the founding CEO of Tempest Therapeutics Inc. (NASDAQ:TPST). ImmuneSensor is targeting the cGAS-STING pathway to treat indications in inflammation, autoimmunity and oncology…